November 19, 2019 / 10:58 AM / a month ago

Novartis declines comment on reported interest in Medicines Co

ZURICH, Nov 19 (Reuters) - Swiss drugmaker Novartis on Tuesday declined to comment on a media report that it is considering an offer for U.S. biotechnology company The Medicines Co.

Novartis is courting the maker of investigational drugs for cardiovascular conditions including atherosclerosis, or hardening of the arteries, Bloomberg reported, citing people familiar with the matter. The Medicines Co has a market capitalisation of nearly $4.7 billion after the shares have more than tripled in value this year. (Reporting by John Miller; Editing by Michael Shields)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below